Aktiviteter og publikationer

Aktuelt har vi 3 ph.d.-projekter i afdelingen:

• "Bladder and Bowel Dysfunction in Children"
  Ph.d.-studerende Sofie Axelgaard
• "Effective Pharmacological Treatment and Strategy of Withdrawal in Children with Urinary Incontinence"
  Ph.d.-studerende Ann-Kristine Mandøe Svensen
• "The CHECK study: Cardiovarcular Helth Effect of Childhood Hypertension"
  Ph.d.-studerende Lise Fischer Mikkelsen

• "Effekten af MiniGo som add-on til peroral laksantia til børn med obstipation og fækal inkontinens,"
  Forskningsårsstuderende Signe Øbo Larsen. 

• "A Phase 3, Multicenter, 12-Week, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atogepant for the Preventive Treatment of Episodic Migraine in Pediatric Subjects 6 to 17 years of age."
  Sponsor: Abbvie 
• "An Open-Label Extension of Study HGT-MLD-070 Evaluating Long Term Safety and Efficacy of Intrathecal Administration of HGT-1110 in Patients with Metachromatic Leukodystrophy."
  Sponsor: Shire 
• "A 52-week randomized, double-blind, placebo-controlled, multi-center Phase 2b study with a 52-week blinded extension assessing safety and efficacy of frexalimab, a CD40L-antagonist monoclonal antibody, for preservation of pancreatic beta-cell function in adults and adolescents with newly diagnosed type 1 diabetes on insulin therapy."
  Sponsor: Sanofi 
• "A parallel-group prevention, Phase II, partially blinded, multi-stage study to investigate the immunogenicity and safety of Pentavalent Meningococcal ABCYW Vaccine formulations compared with licensed meningococcal vaccines when administered alone in healthy children (2 to 9 years of age) or concomitantly with routine pediatric vaccines in toddlers (12 to 15 months of age) and infants (2 months of age)."
  Sponsor: Sanofi 
• "A Phase 3a, observer-blind, randomized, controlled, study to evaluate the immunogenicity and safety of an investigational varicella vaccine compared with Varivax, when given as a second dose to healthy children, 3 months after the administration of the first dose at 12 to 15 months of age."
  Sponsor: GSK 
• "A Phase 2, randomized, observer-blind, placebo-controlled study to evaluate the reactogenicity, safety, and immunogenicity of mRNA-1345, an mRNA vaccine targeting respiratory syncytial virus, in pregnant women, and safety and immunogenicity in infants born to vaccinated mothers."
  Sponsor: Moderna

• "Non-neurogenic overactive bladder – a bladder or a brain condition"
  Ph.d-studerende Kristina Thorsteinsson, Aalborg Universitetshospital
  Medvejleder Luise Borch, Regionshospitalet Gødstrup
• "Tæt og tør – et tværsektorielt samarbejde om børn og unge med inkontinens,"
  Aalborg Universitetshospital
  Samarbejde med Luise Borch, Regionshospitalet Gødstrup 
• "Oral versus intravenous empiric antibiotics in children and adolescents with uncomplicated bone and joint infections: a danish, nationwide, randomised, controlled, non-inferiority trial,"
  Rigshospitalet
  Samarbejde med Luise Borch, Regionshospitalet Gødstrup
• "Individualiseret varighed af antibiotisk behandling hos nyfødte med tidlig indsættende infektion,"
  Rigshospitalet
  Samarbejde med Sofie Sommer Hedegaard, Regionshospitalet Gødstrup
• "Less Invasive Surfactant Administration compared to Intubation Surfactant Extubation in premature newborns by mechanical ventilation; a Danish single unit cohort study."
  Rigshospitalet
  Samarbejde med Sofie Sommer Hedegaard, Regionshospitalet Gødstrup 
• "SafeBoosC – III follow-up ".
  Rigshospitalet
  Samarbejde med Sofie Sommer Hedegaard, Regionshospitalet Gødstrup
• "Hvad gør øget simulationstræning på neonatal afdelinger for patientsikkerhedskultur, sygefravær og Apgar score?"
  Pæd-Sim, Aarhus Universitetshospital
  Samarbejde med Sofie Sommer Hedegaard, Regionshospitalet Gødstrup

Her finder du:

• alle publikationer fra Børn og Unge ved Regionshospitalet Gødstrup (link til pure.au.dk)